Psilocybin clinical trials at UCSD

3 in progress, 2 open to eligible people

Showing trials for

  • COMP360 in Participants With TRD

    open to eligible people ages 18 years and up

    Efficacy, Safety, and Tolerability of a single administration of COMP360 in participants with treatment-resistant depression (TRD)

    La Jolla, California and other locations

  • Psilocybin-assisted Therapy for Phantom Limb Pain

    open to eligible people ages 18-75

    This double-blind placebo-controlled pilot study seeks to investigate whether psilocybin can be safely administered to people with chronic phantom limb pain (PLP) in a supportive setting with close follow-up, and its effects on pain symptoms and other moods, attitudes, and behaviors. The investigators' primary hypotheses are that psilocybin is safe to administer in people with PLP and that it will reduce scores on measures of pain. The investigators will also assess a number of secondary measures related to the behavioral and neural responses to pain after psilocybin treatment.

    San Diego, California

  • Psilocybin-Assisted Therapy for Physician Well-Being and Burnout

    Sorry, not yet accepting patients

    Through an open-label study involving a small group of UCSD physicians experiencing burnout, the investigators will evaluate the feasibility, safety, and preliminary effectiveness of PAT to reduce burnout symptoms.

Our lead scientists for Psilocybin research studies include .

Last updated: